| |
Outpatients (n = 150)
|
Inpatients (n = 158)
|
|---|
|
Variable
|
ESBL-positive
|
ESBL-negative
|
Odds Ratio (95 % CI)
|
P-value
|
ESBL-positive
|
ESBL-negative
|
Odds Ratio (95 % CI)
|
P-value
|
|---|
| |
(n = 68)
|
(n = 82)
| | |
(n = 111)
|
(n = 47)
| | |
|---|
|
Sex
| | | |
<0.001
| | | |
0.724
|
|
F (n = 129)
|
16
|
48
|
1
| |
47
|
18
|
1
| |
|
M (n = 179)
|
52
|
34
|
4.59 (2.14–9.84)
| |
64
|
29
|
0.85 (0.42–1.70)
| |
|
Source of isolates
| | | |
0.019
| | | |
0.139
|
|
Urine sample (n–185)
|
59
|
60
|
1
| |
48
|
18
|
1
| |
|
Pus (n = 56)
|
06
|
07
|
0.87 (0.28–2.75)
| |
32
|
11
|
1.09 (0.46–2.61)
| |
|
Aspirate (n = 38)
|
02
|
03
|
0.68 (0.11–4.20)
| |
24
|
09
|
1.00 (0.39–2.56)
| |
|
Othera (n = 29)
|
01
|
12
|
0.08 (0.01–0.67)
| |
07
|
09
|
0.29 (0.09–0.90)
| |
|
Age
| | | |
<0.001
| | | |
0.607
|
|
≤28 days
|
01
|
02
|
1
| |
09
|
04
|
1
| |
|
>28 days–1 year
|
01
|
08
|
0.20 (0.01–4.72)
| |
07
|
04
|
0.78 (0.14–4.27)
| |
|
>1–5 years
|
02
|
15
|
0.31 (0.02–5.19)
| |
06
|
06
|
0.44 (0.09–2.28)
| |
|
>5–15 years
|
04
|
07
|
1.14 (0.08–16.95)
| |
30
|
12
|
1.11 (0.29–4.31)
| |
|
>15–65 years
|
44
|
45
|
1.96 (0.17–22.35)
| |
49
|
19
|
1.15 (0.32–4.17)
| |
|
>65 years
|
16
|
05
|
6.40 (0.47–86.34)
| |
10
|
02
|
2.22 (0.33–15.18)
| |
- Abbreviations: CI confidence interval, ESBL extended-spectrum beta-lactamase, F females, M males, n number
- aOther: stool, cerebrospinal fluid, blood samples and high vaginal swabs
